Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
West J Med ; 167(4): 233-7, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9348752

RESUMO

Pharmacotherapy represents one of the most important ways in which the practice of geriatric medicine differs from conventional medical care. The older patients is a major consumer of prescription and nonprescription medications, and proper use of these agents can lead to more cost-effective strategies in reaching optimal health. A key difference in distinguishing appropriate from inappropriate drug use is evident in the themes of polymedicine and polypharmacy. Polymedicine describes the use of medications for an older population for the treatment of multiple co-morbid conditions, while polypharmacy represents a less-than-desirable state with duplicative medications, drug-to-drug interactions, and inadequate attention to pharmacokinetic and pharmacodynamic principles. The purpose of this paper is to outline strategies toward optimal medication use as a key to successful aging. Specifically, we discuss themes of cost-effective prescribing, the role of medication compliance, overuse and underuse of medication, over-the-counter products, alcohol abuse, and preventive medicine. In addition, we discuss policy implications and responsibility for ensuring the high quality of pharmaceutical care. The reader should have a practical understanding of the pertinent issues in geriatric clinical pharmacology and its relationship to successful aging.


Assuntos
Envelhecimento/fisiologia , Tolerância a Medicamentos/fisiologia , Preparações Farmacêuticas/administração & dosagem , Polimedicação , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Interações Medicamentosas , Uso de Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Feminino , Avaliação Geriátrica , Humanos , Masculino , Cooperação do Paciente , Preparações Farmacêuticas/metabolismo , Formulação de Políticas , Fatores de Risco , Responsabilidade Social , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA